ReviewFrontiers in microbiology2017
Sixty Years (1957-2017) of Research on Toxoplasmosis in China-An Overview.
Review in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
52 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Deciphering the epidemiological dynamics:Frontiers in cellular and infection microbiology · 2024Pooled it
- Seroprevalence of Toxoplasma gondii infection in blood donors in mainland China: a systematic review and meta-analysis.Parasite (Paris, France) · 2018Pooled it
- Seroepidemiology of Toxoplasma gondii infection in people with alcohol consumption in Durango, Mexico.PloS one · 2021Trial
- Prevalence and genetic characterization ofParasite epidemiology and control · 2026Article
- Seroprevalence ofVeterinary sciences · 2026Article
- Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii.Parasites & vectors · 2026Article
- Collaboration, impact, and research trends at the veterinary research institutes of the Chinese Academy of Agricultural Sciences: a bibliometric analysis from 2009 to 2023.BMC veterinary research · 2026Article
- Live attenuated RHΔtkl1 and PruΔpp2a-c mutants of Toxoplasma gondii are promising vaccine candidates conferring protection in pigs.Infectious diseases of poverty · 2026Article
- Anti-Toxoplasma activity of NBMPR is mediated through the inhibition of nucleoside and nucleobase transporters.Parasitology research · 2026Article
- Population genetic structure of zoonoticScience in One Health · 2026Article
- Recombinant ROP6 protein expressed in Saccharomyces cerevisiae INVSc1 cells induced strong immune response and provided significant protection against toxoplasmosis.Scientific reports · 2025Article
- Immunogenicity and Protective Efficacy of a RecombinantVaccines · 2025Article
- The development and excretion of Toxoplasma gondii oocyst manipulate the gut microbiota in its definitive host.Parasites & vectors · 2025Article
- Seroepidemiology of porcine toxoplasmosis: A cross-sectional study in Bosnia and Herzegovina.Veterinary medicine and science · 2025Article
- Molecular Prevalence and Genotyping ofAnimals : an open access journal from MDPI · 2025Article
- Inhibition of GPX4 byCells · 2025Article
- Clinical Manifestations of Ocular Toxoplasmosis in Hubei, China: Case Series.Current medical science · 2025Article
- Article
- Establishment of an ELISA for detecting oocyst-derivedFrontiers in veterinary science · 2025Article
- Analysis of the Correlation BetweenPathogens (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.